Gagnon Robert E.insider trades

In SEC Form 4 filings, Gagnon Robert E. is listed as Director of Bone Biologics Corp (BBLG) and Chief Financial Officer of Opus Genetics, Inc. (IRD). In the last 90 days, Gagnon Robert E. sold $127.2K of Opus Genetics, Inc. (IRD) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
BBLGBone Biologics Corp	Director	1	Sep 30
IRDOpus Genetics, Inc.	Chief Financial Officer	1	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
BBLGBone Biologics Corp	Sep 28	Sep 30	A · derivative	113,896	$0.50	$56,948	113,896	No	Form 4
IRDOpus Genetics, Inc.	Sep 3	Sep 8	S	28,000	$4.54	Sale −$127,212	556,375	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.